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論 文 内 容 の 要 旨 
 
Introduction 
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been 
known to selectively show its cytotoxic function against various types of cancer 
cells without harming normal healthy cells. TRAIL triggers target cell death by 
inducing apoptosis through its specific death receptors, DR4/TRAIL-R1 or 
DR5/TRAIL-R2. Recently, several clinical trials have been conducted to test the 
application of TRAIL in cancer therapy by using recombinant TRAIL or agonistic 
monoclonal antibodies against TRAIL death receptors either as a mono-therapy 
or as a combination therapy with other anti-cancer drugs. Despite the specificity 
of TRAIL-induced cell death in cancer cells, cell intrinsic and extrinsic TRAIL 
resistance has been often observed in many cancer cell types. Such 
TRAIL-resistance could associate with defects in TRAIL death receptor 
signalling or dys-regulation of anti-apoptotic proteins controlled by pro-survival 
machinery often over-activated in cancer cells. In this study, I aim to explore the 
utility of natural products to design the effective cancer therapy targeting 
TRAIL-induced cancer cell death by facilitating the TRAIL-mediated cytotoxicity 
or by overcoming TRAIL resistance in cancer cells.  
 
1. Identification of natural products enhancing TRAIL-targeted therapy (1,2) 
To identify natural products that can enhance the efficacy of TRAIL-targeted 
therapy, I first screened 55 chemical structure-defined compounds and 138 
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water extracts from natural products in their efficacy combined with 
TRAILinduced cell death against human breast cancer cell lines (TNBC). 
MDA-MB-231 and MDA-MB-468 cells were used as a TRAIL-sensitive and 
TRAILresistant cell line, respectively. Among the screened compounds, I found 
that piperine showed highly synergistic effect to TRAIL-induced apoptosis 
against human breast cancer cells in vitro. In addition to its effect on 
TRAIL-induced apoptosis, piperine also suppressed the expression survivin and 
the phosphorylation of p65, both has been known to associate with 
anti-apoptotic machinery of cancer cells. Importantly, I further demonstrated that 
in vivo piperine treatment potentiated tumor suppressive effect of TRAIL-targeted 
therapy by using agonistic monoclonal antibodies against TRAIL death receptor 
5 (anti-DR5 mAb) in murine 4T1 breast cancer model. Of note, the combination 
treatment of anti-DR5 mAb and piperine inhibited spontaneous lung metastasis 
of 4T1 tumor along with the inhibition of primary tumor growth,and further 
prolonged survival rates of tumor-bearing mice. In addition to piperine, I have 
also identified the extracts of Uvaria dac (Ud) and Artemisia vulgaris (Av) strongly 
enhanced TRAIL-induced apoptosis. Both Ud and Av extracts suppressed the 
phosphorylation of p65 and further the oral administration of Ud enhanced the 
efficacy of TRAIL-targeted therapy by anti-DR5 mAb in 4T1 breast cancer 
model. 
 
2. Chrysin as an active component of the Propolis extract to enhance 
TRAIL-targeted therapy (3,4) 
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It has been known that the ability of Propolis extract (bee glue) to potentiate 
TRAIL-induced apoptosis, however the active ingredient of the Propolis extract 
responsible for enhancing TRAIL effect was not explored. Therefore, 
Iinvestigated the efficacy of chrysin and tectochrysin that are the major isolated 
constituents of Propolis extract, in combination with TRAIL-induced cell death in 
human cancer cell lines. By testing those two major compounds of Propolis 
extract, I found that chrysin showed a potent effect on enhancing TRAILinduced 
apoptosis in both A549 lung cancer cells and HeLa cervical cancer cells. In 
accordance with its pro-apoptotic effect in combination with TRAIL,chrysin 
down-regulated the protein and the gene expression of MCL-1 antiapoptotic 
molecule. The contribution of MCL-1 in TRAIL resistance was confirmed by 
using siRNA knockdown of MCL-1. Additionally, the suppression of MCL-1 by 
chrysin may be through the suppression of up-stream STAT3 phosphorylation 
because the treatment of STAT3-specific chemical inhibitor,cucurbitacin-I, also 
decreased the MCL-1 levels and enhanced TRAIL-induced apoptosis. In 
addition to its effect on TRAIL-induced apoptosis, I also found that chrysin 
inhibits hypoxia-induced STAT3 phosphorylation and VEGF gene expression in 
4T1 cells. Finally, I showed the in vivo treatment of chrysin significantly 
suppressed primary 4T1 tumor growth and further enhanced the anti-metastatic 
activity of TRAIL-targeted therapy by using anti-DR5 mAb in 4T1 model. 
 
Conclusion 
In this study, I identified piperine and the extract of Ud and Av as novel 
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enhancers for cancer therapy targeting TRAIL-induced cancer cell death in 
accordance with the inhibition of anti-apoptotic machinery. Furthermore, I also 
identified chrysin as an active ingredient of the Propolis extract responsible for 
enhancing TRAIL effect possibly through the inhibition of MCL-1/STAT3 axis. 
Collectively, the present results clearly indicate the utility of those natural 
products to develop novel TRAIL-targeted combination therapies against cancer. 
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